Report cover image

U.S. Breast Prosthetic Market Size, Share, Trends, Industry Analysis Report By Product (Silicone Prosthesis, Foam Prosthesis), By Material, By Usage, By Distribution Channel– Market Forecast, 2025–2034

Published Jul 01, 2025
Length 125 Pages
SKU # PLRS20324456

Description

The U.S. breast prosthetic market size is expected to reach USD 271.85 million by 2034, according to a new study by Polaris Market Research. The report “U.S. Breast Prosthetic Market Size, Share, Trends, Industry Analysis Report By Product (Silicone Prosthesis, Foam Prosthesis), By Material, By Usage, By Distribution Channel – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

A breast prosthetic is an artificial breast form used to replace the shape of all or part of a breast that has been removed due to mastectomy or other medical conditions. It can be worn externally inside a bra or surgically implanted as a breast implant.

Companies in the U.S. are leaders in prosthetic innovation. Advanced products such as Amoena’s Adapt Air, which features air-adjustable volume and temperature-regulating technology, show how the market is evolving to meet changing needs. These technologies improve comfort, fit, and appearance, making them more attractive to users. Lightweight silicone, skin-safe materials, and natural shapes all add value. As more women experience the benefits of these innovations, demand continues to grow. Continuous research and development ensure the U.S. market stays ahead with products that better support recovery and daily life.

Many women in the U.S. use breast prosthetics to restore body balance and improve appearance. There is growing awareness and acceptance of external breast forms as a lifestyle choice. This is especially among the women who do not wish to undergo reconstructive surgery but still want a natural-looking solution. The demand for lightweight, realistic prosthetics with cosmetic appeal is growing. This trend supports continuous innovation in design, materials, and comfort, helping expand the market beyond just post-surgical users.

U.S. Breast Prosthetic Market Report Highlights

In 2024, the silicone prosthesis segment dominated with the largest share due to its realistic feel, comfort, and long-term durability.

The latex segment is expected to experience significant growth during the forecast period, due to its lower price and improving comfort features.

A few key players in the U.S. breast prosthetic market are AbbVie; American Breast Care; Amoena Medizin-Orthopädie-Technik GmbH; Anita Dr. Helbig GmbH; GC Aesthetics; HansBioMed; Mentor Worldwide LLC; POLYTECH Health & Aesthetics GmbH; SILIMED INDUSTRIA DE IMPANTES LTDA; Tiger Aesthetics Medical, LLC; Trulife; and Valtris Specialty Chemicals.

Polaris Market Research has segmented the U.S. breast prosthetic market report on the basis of product, material, usage, and distribution channel:

By Product (Revenue – USD Million, 2020–2034)

Silicone Prosthesis

Foam Prosthesis

Inflatable Prosthesis

Custom-Fit Prosthesis

Partial Breast Prosthesis

By Material (Revenue – USD Million, 2020–2034)

Silicone

Polyurethane

Gel

Latex

By Usage (Revenue – USD Million, 2020–2034)

Post-Mastectomy

Post-Lumpectomy

Reconstructive Surgery

Cosmetic Improvement

By Distribution Channel (Revenue – USD Million, 2020–2034)

Online Retail

Specialty Stores

Hospitals and Clinics

Pharmacies

Table of Contents

125 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. U.S. Breast Prosthetic Market Insights
4.1. U.S. Breast Prosthetic Market – Market Snapshot
4.2. U.S. Breast Prosthetic Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Number of Breast Cancer Cases
4.2.1.2. Strong Health Insurance Coverage
4.2.2. Restraints and Challenges
4.2.2.1. High Initial Investment
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Breast Prosthetic Market Trends
4.6. Value Chain Analysis
5. U.S. Breast Prosthetic Market, by Product
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Breast Prosthetic Market, by Product, 2020-2034 (USD billion)
5.3. Silicone Prosthesis
5.3.1. U.S. Breast Prosthetic Market, by Silicone Prosthesis, 2020–2034 (USD billion)
5.4. Foam Prosthesis
5.4.1. U.S. Breast Prosthetic Market, by Foam Prosthesis, 2020–2034 (USD billion)
5.5. Inflatable Prosthesis
5.5.1. U.S. Breast Prosthetic Market, by Inflatable Prosthesis, 2020–2034 (USD billion)
5.6. Custom-Fit Prosthesis
5.6.1. U.S. Breast Prosthetic Market, by Custom-Fit Prosthesis 2020–2034 (USD billion)
5.7. Partial Breast Prosthesis
5.7.1. U.S. Breast Prosthetic Market, by Partial Breast Prosthesis, 2020–2034 (USD billion)
6. U.S. Breast Prosthetic Market, by Material
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Breast Prosthetic Market, by Material, 2020-2034 (USD billion)
6.3. Silicone
6.3.1. U.S. Breast Prosthetic Market, by Silicone, 2020–2034 (USD billion)
6.4. Polyurethane
6.4.1. U.S. Breast Prosthetic Market, by Polyurethane, 2020–2034 (USD billion)
6.5. Gel
6.5.1. U.S. Breast Prosthetic Market, by Gel, 2020–2034 (USD billion)
6.6. Latex
6.6.1. U.S. Breast Prosthetic Market, by Latex, 2020–2034 (USD billion)
7. U.S. Breast Prosthetic Market, by Usage
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Breast Prosthetic Market, by Medical Biotechnology, 2020-2034 (USD billion)
7.3. Post-Mastectomy
7.3.1. U.S. Breast Prosthetic Market, by Post-Mastectomy, 2020–2034 (USD billion)
7.4. Post-Lumpectomy
7.4.1. U.S. Breast Prosthetic Market, by Post-Lumpectomy, 2020–2034 (USD billion)
7.5. Reconstructive Surgery
7.5.1. U.S. Breast Prosthetic Market, by Reconstructive Surgery, 2020–2034 (USD billion)
7.6. Cosmetic Improvement
7.6.1. U.S. Breast Prosthetic Market, by Cosmetic Improvement, 2020–2034 (USD billion)
8. U.S. Breast Prosthetic Market, by Distribution Channel
8.1. Key Findings
8.2. Introduction
8.2.1. U.S. Breast Prosthetic Market, by Distribution Channel, 2020-2034 (USD billion)
8.3. Online Retail
8.3.1. U.S. Breast Prosthetic Market, by Online Retail, 2020–2034 (USD billion)
8.4. Specialty Stores
8.4.1. U.S. Breast Prosthetic Market, by Specialty Stores, 2020–2034 (USD billion)
8.5. Hospitals and Clinics
8.5.1. U.S. Breast Prosthetic Market, by Hospitals and Clinics 2020–2034 (USD billion)
8.6. Pharmacies
8.6.1. U.S. Breast Prosthetic Market, by Pharmacies, 2020–2034 (USD billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. AbbVie
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. American Breast Care
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Amoena Medizin-Orthopädie-Technik GmbH
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Anita Dr. Helbig GmbH
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. GC Aesthetics
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. HansBioMed
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Mentor Worldwide LLC
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. POLYTECH Health & Aesthetics GmbH
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. SILIMED INDUSTRIA DE IMPANTES LTDA
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Tiger Aesthetics Medical, LLC
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. Trulife
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development
10.12. Valtris Specialty Chemicals
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Development
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.